Page 88 - TD-4-3
P. 88

Tumor Discovery                                             Mg-28-A theoretical novel strategy in cancer therapy



               and 10.0 Million Deaths in 2020. Available from: https://www.  metabolism:  Insights  and  applications.  Metab  J.
               iarc.who.int/news-events/latest-global-cancer-data-cancer-  2014;48:456-467.
               burden-rises-to-19-3-million-new-cases-and-10-0-million-  15.  Tran VL, Hoang T. Nuclear transformation in
               cancer-deaths-in-2020 [Last accessed on 2025 May 21].
                                                                  metalloenzyme: A novel and high potential cancer treatment
            2.   Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation   research. BioRxiv. 2023.
               therapy: Current advances and future directions. Int J Med      doi: 10.1101/2023.08.10.552823
               Sci. 2012;9:193-199.
                                                               16.  Luyen VT. A proposal for a cancer treatment study involving
               doi: 10.7150/ijms.3635
                                                                  radioactive metal co-factor enzymes. In:  Highlights on
            3.   Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine   Medicine and Medical Science. Vol.  15. West Bengal: BPI;
               in cancer therapy. Sig Transduct Target Ther. 2023;8:293.  2021. p. 1-5.
               doi: 10.1038/s41392-023-01536-y                    doi: 10.9734/bpi/hmms/v15/9276D
            4.   Zahavi D, Weiner L. Monoclonal antibodies in cancer   17.  National Nuclear Data Center.  Mg-28 Beta Decay Data.
               therapy. Antibodies (Basel). 2020;9:34.            Available from: https://www.nndc.bnl.gov/ensnds/28/Mg/
               doi: 10.3390/antib9030034                          beta_decay.pdf [Last accessed on 2025 May 21].
            5.   Kalmouni M, Al-Hosani S, Magzoub M. Cancer targeting   18.  Cowan JA. Structural and catalytic chemistry of magnesium-
               peptides. Cell Mol Life Sci. 2019;76:2171-2183.    dependent enzymes. Biometals. 2002;15:225-235.
               doi: 10.1007/s00018-019-03061-0                    doi: 10.1023/A:1016091118583
            6.   Ratan ZA, Son YJ, Haidere MF,  et  al. CRISPR-Cas9:   19.  Hubscher U, Maga G, Villani G, Spadari S. DNA Polymerases:
               A  promising genetic engineering approach in cancer   Discovery, Characterization and Functions in Cellular DNA
               research. Ther Adv Med Oncol. 2018;10.             Transactions. Singapore: World Scientific Publishing; 2010.
               doi: 10.1177/1758834018755089                   20.  De Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium
                                                                  in  man:  Implications  for  health  and  disease.  Physiol Rev.
            7.   Sterner  RC,  Sterner  RM.  CAR-T  cell  therapy:  Current   2015;95:1-46.
               limitations and potential strategies.  Blood Cancer J.
               2021;11:69.                                        doi: 10.1152/physrev.00012.2014
               doi: 10.1038/s41408-021-00459-7                 21.  Rahm M, Hoffmann R, Ashcroft NW. Atomic and ionic radii
                                                                  of elements 1-96. Chemistry. 2016;22:14625-14632.
            8.   Lee S, Kim J. Advances in radioisotope applications for cancer
               diagnosis and treatment. J Nucl Med. 2019;60:345-357.     doi: 10.1002/chem.201602949
            9.   Krishnamurthy GT, Blahd WH. Radioiodine I-31 therapy   22.  Greenwood NN, Earnshaw A.  Chemistry of the Elements.
                                                                   nd
               in the management of thyroid cancer. A prospective study.   2  ed. Oxford: Butterworth-Heinemann; 1997.
               Cancer. 1977;40:195-202.                        23.  Fenton E.  Silicon Biochemistry. Hoboken, New Jersey:
               doi: 10.1002/1097-0142(197707)40:1<195::AID-CNCR2820   Wiley-Interscience; 2001.
               400131>3.0.CO;2-C                               24.  National Institute of Standards and Technology.  E-STAR
            10.  Tran  TVT,  Rubino  C,  Allodji  R,  et al.  Breast  cancer  risk   Program: Electron Stopping Power Data.  Available  from:
               among thyroid cancer survivors and the role of I-131   https://physics.nist.gov/PhysRefData/Star/Text/ESTAR.
               treatment. Br J Cancer. 2022;127:2118-2124.        html [Last accessed on 2025 May 21].
               doi: 10.1038/s41416-022-01982-5                 25.  National  Nuclear  Data  Center.  Al-28 Beta Decay Data.
                                                                  Available from: https://www.nndc.bnl.gov/ensnds/28/Al/
            11.  Castiglioni S, Farruggia G, Cappadone C.  Magnesium in   beta_decay.pdf [Last accessed on 2025 May 21].
               Human Health and Disease. MDPI Books; 2021. Available
               from:  https://www.mdpi.com/books/pdfview/book/4389  26.  National Nuclear Data Center.  MIRD Program. Available
               [Last accessed on 2025 May 21].                    from:   https://www.nndc.bnl.gov/nudat3/mird/  [Last
                                                                  accessed on 2025 May 21].
            12.  Smith A, Jones B, Williams C. Utilization of magnesium-28
               as a tracer in metabolic studies. J Metab Res. 2012;45:233-245.  27.  Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
            13.  Brown R, Green P, Taylor M. Tracking magnesium uptake      doi: 10.1126/science.274.5293.1672
               and distribution using Mg-28. BioMetals. 2016;29:163-178.
                                                               28.  Nelson DL, Cox MM. Lehninger Principles of Biochemistry.
            14.  Johnson L, Thompson D. Magnesium-28 in cellular   6  ed. United States: W. H. Freeman and Company.
                                                                   th




            Volume 4 Issue 3 (2025)                         80                           doi: 10.36922/TD025070010
   83   84   85   86   87   88   89   90   91   92   93